[-] Show simple item record

dc.contributor.authorRodriguez, Jose E.eng
dc.contributor.authorShearer, Barbaraeng
dc.date.issued2007-11eng
dc.description.abstractNo studies have addressed the question of whether metformin reduces development of diabetes among adolescents who are obese. Metformin treatment in adolescents who are obese can modestly reduce risk factors for type 2 diabetes, including elevated body mass index (BMI), fasting insulin levels, and fasting glucose levels. (Strength of Recommendation [SOR]: C). However, metformin treatment is associated with nausea, abdominal pain, and diarrhea. (SOR: A). Because of the limited available data, metformin is not recommended for diabetes prevention in adolescents. (SOR: C).eng
dc.identifier.citationAmerican Family Physician, 76(9) 2007.eng
dc.identifier.urihttp://hdl.handle.net/10355/3978eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofClinical Inquiries, 2007 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectobesityeng
dc.subjecttype 2 diabeteseng
dc.subjectlifestyle modificationeng
dc.subjectpolycystic ovary syndromeeng
dc.subject.lcshMetformineng
dc.subject.lcshObesity in childreneng
dc.subject.lcshNon-insulin-dependent diabeteseng
dc.titleMetformin Therapy and Diabetes Prevention in Adolescents Who Are Obeseeng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record